StockNews.com lowered shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a research note published on Wednesday. A number of other equities analysts have also weighed in on the company. Oppenheimer reiterated an outperform rating and set a $10.00 target price on shares of Aldeyra Therapeutics in […]
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price […]
Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight analysts that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month […]
StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a research report released on Tuesday morning. Several other equities analysts have also commented on the company. HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of Aldeyra Therapeutics in a […]
Acrivon Therapeutics (NASDAQ:ACRV) Receives Outperform Rating from BMO Capital Markets themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.